Eyesight

The new drug, Vuity, adjusts pupil size and corrects near vision without affecting distance vision, drugmaker Allergan says.

The FDA has approved an ocular implant that could reduce the treatment schedule from monthly to twice yearly for older adults with “wet” macular degeneration.

Sprayed twice daily into each nostril, Tyrvaya reduced eye dryness within four weeks in clinical trials. The medication will be available by prescription beginning in November, the developer says.

The Food and Drug Administration has approved a less expensive copy of the blockbuster drug Lucentis for treating age-related (wet) macular degeneration and several other eye conditions.

Trial participants reported significant near-vision improvements under low-light conditions — without losing distance vision, reports Allergan, which is seeking FDA approval for the drug.

Ocular hypertension led to glaucoma in about half of patients over two decades, and to at least some vision loss in 25%. The findings may help clinicians and patients make personalized choices about managing...

J&J shipment of 15 million vaccines halted due to manufacturing error … NIH: Preventive treatment slows eye damage in diabetes … Unhealthy gums tied to higher systolic blood pressure in healthy...

The prevalence of impairment fell significantly between 2008 and 2017, with much of the decline among adults aged 75 years and older, researchers say.

Drugmaker Allergan is seeking federal approval for a new eye drop that treats presbyopia, the common age-related vision loss that often prompts a need for reading glasses.

Parkinson’s patients carry a heavy burden of eye disease, but treatment can help improve daily function, say researchers.